Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Clinical trial NCT02281318 · COMPLETED
Trial details
- NCT number
- NCT02281318
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-11
- Primary completion
- 2016-06-10
- Enrollment
- 556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.